Why Early Companies Partner for Research
Most early life science companies are built around a discovery made in someone else’s lab. The next experiments decide what the company is worth, but a dedicated lab, its equipment and its staff take time and capital that a company at this stage rarely has.
Working through partner labs and shared facilities turns that fixed cost into a planned one. The company pays for the studies it needs, when it needs them, and keeps its capital for the decisions the data supports.
What a Partnership Covers
We start with the research strategy: the questions a licensee, partner or investor will ask, the studies that answer them, and the order that answers the most important questions first. From there we help select labs and facilities suited to the method and the materials, agree scope, timelines and data standards, and manage the vendor relationships as the work runs.
The result is a data package built for the next decision rather than a stack of reports, and a team that understands what was learned and what comes next.
Where It Fits in Commercialization
Research and company building are intertwined, not separate steps. The same plan connects to intellectual property (what the data has to show to support claims), to regulatory strategy (which studies will matter later), and to fundraising (which milestones unlock the next round). We keep those threads together so each study earns its place.
